Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vicodin CR in chronic low back pain
NCT00761150Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Sep 2008
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of hydrocodone in chronic low back pain (CLBP) (3 arms), sponsored by AbbVie Inc. Primary endpoint: Change From Double-blind Baseline to Final Assessment in Chronic Lower Back Pain Intensity by Visual Analog Scale at 4 weeks. Started Sep 2008; status: completed.
02
Drugs
hydrocodone
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT00761150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00761150.